Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.
about
Nitric oxide and pH modulation in gynaecological cancerChemoresistance and targeted therapies in ovarian and endometrial cancersGenetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapyPhosphorylated TP63 induces transcription of RPN13, leading to NOS2 protein degradationVitamin E, Vitamin C, or Losartan Is Not Nephroprotectant against Cisplatin-Induced Nephrotoxicity in Presence of Estrogen in Ovariectomized Rat Model.Effect of enalapril in cisplatin-induced nephrotoxicity in rats; gender-related differenceTargeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma.Dual role of macrophages in the response of C26 colon carcinoma cells to 5-fluorouracil administration.Patterns Prediction of Chemotherapy Sensitivity in Cancer Cell lines Using FTIR Spectrum, Neural Network and Principal Components Analysis.The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer.Mechanisms of resistance to photodynamic therapy.Essential roles of the nitric oxide (no)/cGMP/protein kinase G type-Iα (PKG-Iα) signaling pathway and the atrial natriuretic peptide (ANP)/cGMP/PKG-Iα autocrine loop in promoting proliferation and cell survival of OP9 bone marrow stromal cells.Angiotensin Type-1 Receptor Blockade May Not Protect Kidney against Cisplatin-Induced Nephrotoxicity in Rats.Glucagon-like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus.MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment.Identification of genes and pathways associated with MDR in MCF-7/MDR breast cancer cells by RNA-seq analysis.
P2860
Q26741063-C658CC36-95E1-42EB-A292-BBDCAA14702FQ28073246-EC5AE651-AFED-4FA0-AFFB-DB35B899323DQ33757947-04911DCD-429E-4FBF-989D-2520F0F1A012Q34438764-7900D4AB-F761-4713-A413-8A5D689D6B72Q36296439-CD538AFD-4BDA-47A0-A420-3534378A9BF0Q36629047-FDCC701B-51A5-4F88-919C-E18F99873784Q36991145-E149A812-7BCC-490F-B95C-5967F6F5740BQ37108231-AB2C4BD0-D1F1-4B41-A91F-E1ED6542086BQ37320185-F2CF6EA6-055F-4B49-90A2-1855F3CE73F5Q37651305-B71DBD41-8A66-4D87-AAD5-83BF3EA8B50FQ37875160-305B2C06-FB02-4D3F-9850-47A334D4704DQ39590590-D97A15BE-FCF5-4125-B5EB-FB1D5802C4B1Q40309818-9B617635-DCD0-4721-9435-E0C3FC35F51EQ40345569-1C6B132D-0DF2-461C-B373-EDCCD011B150Q47890192-6DD9056D-9A05-498C-B932-1153337C1266Q52669994-8023F741-5A10-45D4-8D3C-B08D31E698EC
P2860
Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cisplatin alters nitric oxide ...... tion and cisplatin resistance.
@ast
Cisplatin alters nitric oxide ...... tion and cisplatin resistance.
@en
type
label
Cisplatin alters nitric oxide ...... tion and cisplatin resistance.
@ast
Cisplatin alters nitric oxide ...... tion and cisplatin resistance.
@en
prefLabel
Cisplatin alters nitric oxide ...... tion and cisplatin resistance.
@ast
Cisplatin alters nitric oxide ...... tion and cisplatin resistance.
@en
P2093
P2860
P356
P1476
Cisplatin alters nitric oxide ...... ation and cisplatin resistance
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604375
P407
P577
2008-05-27T00:00:00Z